Blog

Ikigai Law acted on Doxper’s US$4 million fund raise from Alkemi Ventures. [1] The round also saw participation from Rainforest Venture Network, existing investor growX Ventures and angel investors. Doxper provides a digital pen and encoded paper-based solution to helps doctors and hospitals automatically digitise health records. Since doctors continue to use pen and paper there is a ‘zeroRead more

Healthcare in India is plagued with problems – a severe shortage of hospitals, doctors and other health service providers; a large section of the population which is poor and does not have access to health care; and inadequate governmental spending and support[1]. Despite the fact that India is behind more developed countries in the adoptionRead more

1. Central Government At the sixth session of the Conference of the Parties to the WHO Framework Convention on Tobacco Control held in October 2014, parties were urged to consider regulating or prohibiting Electronic Nicotine Delivery System (“ENDS”) and restricting or banning advertisement and promotion of ENDS.[1] A national level Roundtable Discussion was held inRead more

Update for all players interested in the medical, pharmaceutical and/or health-tech industry. The Ministry of Health and Family Welfare has notified the New Drugs and Clinical Trial Rules, 2019 (“New Rules”). Prior to this notification clinical trials in India were governed by a scattered set of rules and guidelines mainly found under the Drugs and Cosmetic Act,Read more

The National Health Policy, 2017[1] (“Policy”) envisaged the creation of a digital health technology ecosystem, aiming to leverage the potential of digital health data. The advantages of such digitalization and the potential of technology can hardly be overlooked, yet the proposals in this policy essentially involve large-scale creation, collection and sharing of health data. AnRead more